Colgate-Palmolive Company (CL) reports earnings

Colgate-Palmolive Company (CL) has filed its Form 10-K filing for the fiscal year ended December 31, 2024.

The filing reports a net sales increase of 3.3% to $20.1 billion, driven by volume growth and price increases, partially offset by foreign exchange impacts.

The Oral, Personal and Home Care segment reported net sales of $15.6 billion, a 3.0% increase, with organic sales growth of 8.1%.

Hill’s Pet Nutrition segment achieved net sales of $4.5 billion, up 4.5% from the previous year, with organic sales growth of 4.9%.

Gross profit increased to $12.2 billion, with a gross profit margin of 60.5%, up from 58.2% in the previous year.

Operating profit rose 7% to $4.3 billion, with an operating profit margin of 21.2%, reflecting higher gross profit offset by increased selling, general, and administrative expenses.

Net income attributable to Colgate-Palmolive Company was $2.9 billion, or $3.51 per diluted share, up from $2.3 billion, or $2.77 per diluted share, in 2023.

The company identified a material weakness in its internal controls over financial reporting due to a lack of resources with SEC financial reporting experience.

Colgate-Palmolive does not anticipate cash dividend payments to common stockholders in the near future.

The company continues to focus on marketing its products globally, with a significant portion of sales coming from emerging markets.

This content was summarized by generative artificial intelligence using public filings retrieved from SEC.gov. The original data was derived from the Colgate-Palmolive Company annual 10-K report dated February 13, 2025. To report an error, please email [email protected].